hVIVO plc (LON:HVO – Get Free Report) crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 27.34 ($0.35) and traded as low as GBX 26.50 ($0.34). hVIVO shares last traded at GBX 26.67 ($0.34), with a volume of 2,795,504 shares trading hands.
hVIVO Stock Up 1.2 %
The company has a current ratio of 1.48, a quick ratio of 1.16 and a debt-to-equity ratio of 36.50. The stock has a market cap of £185.54 million, a P/E ratio of 1,333.30 and a beta of 1.02. The company’s 50 day moving average price is GBX 27.34 and its two-hundred day moving average price is GBX 27.19.
hVIVO Cuts Dividend
The business also recently announced a dividend, which was paid on Monday, May 20th. Investors of record on Thursday, April 18th were given a dividend of GBX 0.20 ($0.00) per share. The ex-dividend date was Thursday, April 18th. This represents a yield of 0.68%.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Recommended Stories
- Five stocks we like better than hVIVO
- How to Find Undervalued Stocks
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- How to Invest in the FAANG Stocks
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.